Day: October 29, 2024

Udemy Reports Third Quarter 2024 Results

Delivered stronger-than-expected profitability driven by disciplined approach to operational efficiency Surpassed $500 million in Udemy Business Annual Recurring Revenue Raises Full Year 2024 Outlook SAN FRANCISCO, Oct. 29, 2024 (GLOBE NEWSWIRE) — Udemy (Nasdaq: UDMY), a leading online skills marketplace and learning platform, today reported results for the three-month period ended September 30, 2024. Udemy has provided a supplemental deck with earnings highlights, which is available for download on the “Quarterly Results” section of the Investor Relations website. Third Quarter 2024 Financial Results and Key Operating Data Summary(in millions, except customers, percentages, and basis points)   Three Months Ended September 30,   % Change   Nine Months Ended September 30,   % Change   2024   2023   YoY   2024   2023   YoY Revenue $ 195.4       $ 184.7       6   %   $ 586.6       $ 539.4       9   % Gross...

Continue reading

CVRx Reports Third Quarter 2024 Financial and Operating Results

MINNEAPOLIS, Oct. 29, 2024 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the third quarter of 2024. Recent Highlights Total revenue for the third quarter 2024 was $13.4 million, an increase of 27% over the prior year quarter U.S. Heart Failure (HF) revenue for the third quarter of 2024 was $12.2 million, an increase of 30% over the prior year quarter Active implanting centers in the U.S. were 208, an increase of 31% over the prior year quarter Final Inpatient Prospective Payment System rule confirmed the reassignment of Barostim to MS-DRG 276, increasing payment to hospitals from approximately...

Continue reading

Varonis Announces Third Quarter 2024 Financial Results

Annual recurring revenues grew 18% year-over-yearSaaS ARR as a percentage of total ARR was approximately 43%Year-to-date cash from operations generated $90.9 million vs. $49.0 million last yearYear-to-date free cash flow generated $88.6 million vs. $46.0 million last year NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) — Varonis Systems, Inc. (Nasdaq: VRNS), a leader in data security, today announced financial results for the third quarter ended September 30, 2024. Yaki Faitelson, Varonis CEO, said, “We are encouraged by the many tailwinds that are contributing to the strong growth in our business, and our third quarter results reflect the continued strong adoption of our SaaS platform and positive momentum from our Managed Data Detection and Response offering.” Guy Melamed, Varonis CFO & COO, added, “The robust demand for...

Continue reading

Skyward Specialty Insurance Group Reports Third Quarter 2024 Results

HOUSTON, Oct. 29, 2024 (GLOBE NEWSWIRE) — Skyward Specialty Insurance Group, Inc. (Nasdaq: SKWD) (“Skyward Specialty” or the “Company”) today reported third quarter 2024 net income of $36.7 million, or $0.89 per diluted share, compared to $21.7 million, or $0.57 per diluted share, for the same 2023 period. Net income for the first nine months of 2024 was $104.4 million, or $2.53 per diluted share, compared to $56.7 million, or $1.50 per diluted share, for the same 2023 period. Adjusted operating income(1) for the third quarter of 2024 was $29.4 million, or $0.71 per diluted share, compared to $25.0 million, or $0.65 per diluted share, for the same 2023 period. Adjusted operating income(1) for the first nine months of 2024 was $93.4 million, or $2.26 per diluted share, compared to $56.5 million, or $1.49 per diluted share, for the...

Continue reading

Stryker reports third quarter 2024 operating results

Portage, Michigan, Oct. 29, 2024 (GLOBE NEWSWIRE) — reported operating results for the third quarter of 2024: Third Quarter Results Reported net sales increased 11.9% to $5.5 billion Organic net sales increased 11.5% Reported operating income margin of 19.7% Adjusted operating income margin(1) increased 130 bps to 24.7% Reported EPS increased 20.0% to $2.16 Adjusted EPS(1) increased 16.7% to $2.87   Third Quarter Net Sales Growth Overview   Reported   Foreign Currency Exchange   Constant Currency   Acquisitions / Divestitures   Organic MedSurg and Neurotechnology         12.8         %           (0.1)        %           12.9         %           0.2         %           12.7         % Orthopaedics and Spine         10.7                     (0.1)                      10.8                     1.1                     9.7           Total         11.9         %           (0.1)        %           12.0         %           0.5         %           11.5         % “We...

Continue reading

Gibson Energy Announces 2024 Third Quarter Results and 2024 Record Crude Volumes at Edmonton Terminal

All financial figures are in Canadian dollars unless otherwise noted CALGARY, Alberta, Oct. 29, 2024 (GLOBE NEWSWIRE) — Gibson Energy Inc. (TSX:GEI) (“Gibson” or the “Company”) announced today its financial and operating results for the three and nine months ended September 30, 2024. “Gibson delivered strong results in the third quarter, driven by the continued strength and stability of our Infrastructure segment, which now represents over 85% of our business, and saw 2024 record third party crude volumes at our Edmonton Terminal in the third quarter, driven by deliveries onto the Trans Mountain Expansion pipeline,” said Curtis Philippon, President and Chief Executive Officer. “Since joining Gibson in August, I have had the opportunity to visit all of our operations. Gibson’s critical...

Continue reading

Qorvo® Announces Fiscal 2025 Second Quarter Financial Results

GREENSBORO, N.C., Oct. 29, 2024 (GLOBE NEWSWIRE) — Qorvo® (Nasdaq:QRVO), a leading global provider of connectivity and power solutions, today announced financial results for the Company’s fiscal 2025 second quarter ended September 28, 2024. On a GAAP basis, revenue for Qorvo’s fiscal 2025 second quarter was $1.047 billion, gross margin was 42.6%, operating income was $9.7 million, and loss per share was $0.18. On a non-GAAP basis, gross margin was 47.0%, operating income was $212.2 million, and diluted earnings per share was $1.88. Bob Bruggeworth, president and chief executive officer of Qorvo, said, “In the September quarter, ACG successfully supported our largest customer’s seasonal smartphone ramp. In HPA, we expanded our D&A business while building a broad-based business in power management. In CSG, we maintained our...

Continue reading

The Honest Company to Report Third Quarter Financial Results on November 12, 2024

LOS ANGELES, Oct. 29, 2024 (GLOBE NEWSWIRE) — The Honest Company (NASDAQ: HNST), a personal care company dedicated to creating cleanly-formulated and sustainably-designed products, today announced that it will report third quarter 2024 financial results after the market closes on Tuesday, November 12, 2024. The Company will host an investor conference call and webcast to review third quarter 2024 financial results at 1:30pm PT/4:30pm ET on the same day. The live webcast can be accessed at https://investors.honest.com or https://edge.media-server.com/mmc/p/tt3gkzq2. For those interested in participating in the conference call by phone, please go to this link: https://register.vevent.com/register/BI05f7626bb1a14d23b819b1fec89c6138 and you will be provided with dial-in details directly to your registered email. To avoid delays, we...

Continue reading

RBAZ Bancorp, Inc. Announces Unaudited Financial Results For the Quarter Ending September 30, 2024

Net Interest Margin Up 22% QoQ PHOENIX, Oct. 29, 2024 (GLOBE NEWSWIRE) — RBAZ Bancorp, Inc. (OTCIQ: RBAZ) (the “Company”), parent company of Republic Bank of Arizona (the “Bank” or “RBAZ”), announced a consolidated net income of $981,000, or $0.55 per share, for the quarter ended September 30, 2024 and $2,586,000, or $1.45 per share, for the nine months ended September 30, 2024 as compared to a consolidated net income of $748,000, or $0.41 per share, for the quarter ended September 30, 2023 and $1,771,000, or $0.98 per share, for the nine months ended September 30, 2023. President and CEO Brian Ruisinger stated “I am pleased with our strong Q3 earnings performance as we achieved a 22% increase in our net interest margin while the increase in overhead costs was nominal at 2% from the year ago quarter. Net interest margin was bolstered...

Continue reading

Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company

Regained compliance without effecting a reverse stock split Tevogen Bio CEO reaffirms his commitment to preserve shareholder value WARREN, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, announced today that on October 28, 2024, it received written notice from the Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has regained compliance with the minimum bid price requirement (the “Minimum Bid Price Requirement”), as set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Global Market. Tevogen was notified by Nasdaq on June 14, 2024, that it...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.